3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI

• Status: Recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the clinical outcomes of dual antiplatelet therapy with aspirin and P2Y12 receptor inhibitor vs. ticagrelor monotherapy at 3 months after PCI in patients with ST-elevation myocardial infarction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dong-A University
• Treatments: Aspirin; Ticagrelor

Criteria

Inclusion Criteria:

• Patients ≥ 19 years old

• Patients who received new generation sirolimus-eluting (Osiro®) stent implantation for treating ACS

• Provision of informed consent

Exclusion Criteria:

• Age > 80 years

• Pregnant women or women with potential childbearing

• Life expectancy < 1 year